Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
CNMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$46.00 - $78.58
Previous CloseN/A
Volume49.43K
Average Volume (3M)517.82K
Market Cap
$1.85B
Enterprise Value$2.62B
Total Cash (Recent Filing)$35.48M
Total Debt (Recent Filing)$892.16M
Price to Earnings (P/E)15.7
Beta0.53
Next Earnings
Jul 23, 2025EPS Estimate
1.12Next Dividend Ex-Date
Jun 13, 2025Dividend Yield1.39%
Share Statistics
EPS (TTM)0.95
Shares Outstanding30,939,865
10 Day Avg. Volume334,809
30 Day Avg. Volume517,824
Financial Highlights & Ratios
PEG Ratio-1.42
Price to Book (P/B)1.81
Price to Sales (P/S)0.00
P/FCF Ratio10.73
Enterprise Value/Market Cap1.42
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit3.59
Enterprise Value/Ebitda2.81
Forecast
1Y Price Target
$62.20Price Target Upside10.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Conmed News
PremiumCompany Announcements
Conmed Shareholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
Conmed Corporation’s Earnings Call: Mixed Results Amid Growth and ChallengesBulls Say, Bears Say
Bulls Say
Financial PerformanceCNMD's 1Q25 revenue and EPS beat consensus, indicating stronger financial performance than expected.
Management StrategyEfforts to reduce the CNMD leverage profile with a target of ~3x or lower offer the potential for improved performance.
Operational ImprovementsA top-tier consulting firm has been engaged to help remedy ongoing orthopedic supply issues and enhance company operations.
Bears Say
Competition ConcernsThere is concern about Airseal's performance as the ISRG DV5 launch approaches, which could impact CONMED's market position.
Supply Chain ChallengesRevenue growth slowed to 3.8% in 1Q25 from 6.0% in 4Q24 due to supply chain challenges and one less selling day.
Tariff UncertaintiesManagement highlighted a $0.14 expected tariff headwind with no additional mitigation.
Ownership Overview
0.67% Insiders
39.55% Mutual Funds
0.93% Other Institutional Investors
31.67% Public Companies and Individual Investors
CNMD FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was $46.00 and its highest was $78.58 in the past 12 months.
What is Conmed’s market cap?
Conmed’s market cap is $1.85B.
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Jul 23, 2025 which is in 60 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Apr 30, 2025. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.811 by $0.139.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 1.39%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is 1.12.
How many shares outstanding does Conmed have?
Conmed has 30,939,865 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of $0.95 in its last earnings report, beating expectations of $0.811. Following the earnings report the stock price went up 16.453%.
Which hedge fund is a major shareholder of Conmed?
Currently, no hedge funds are holding shares in CNMD
Conmed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$62.20 (10.95% Upside)
$62.20 (10.95% Upside)
Blogger Sentiment
Bullish
CNMD Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 47.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $227.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 7.1%
Last 30 Days ▼ 7.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.35%
12-Months-Change
Fundamentals
Return on Equity
12.96%
Trailing 12-Months
Asset Growth
-0.50%
Trailing 12-Months
Company Description
Conmed
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
CNMD Company Deck
CNMD Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance with strong revenue and earnings growth, improvement in key product segments, and positive cash flow management. However, supply chain challenges, international sales declines, and concerns over tariffs and currency impacts pose significant obstacles.Read More>CNMD Stock 12 Month Forecast
Average Price Target
$62.20
▲( 10.95% Upside)